Baku 23° C
France begins trials of new COVID vaccine
Other countries
- 25 February, 2021
- 06:11
Add Report.az to preferred Google sources
Stay up to date with the top news!
French biotechnology company Xenothera has begun clinical trials of its coronavirus vaccine, Report informs with reference to TASS.
The vaccine is named Xav-19.
The vaccine testing program follows Polycor standards, one of 15 types of clinical trials of drugs approved by the French medical authorities. The trial will be carried out in 40 hospitals in the country, coordinated by the University Hospital of Nantes.
The drug will be tested on 400 volunteer patients. Currently, 67 patients from 21 hospitals are participating in the trial.
The tests are supposed to determine the level of vaccine effectiveness with great accuracy.
Author
Fransada yeni koronavirus peyvəndinin sınaqlarına başlanılır
Во Франции начинаются испытания новой вакцины от COVID-19
Latest News
12:09
AzFina: Development of digital financial ecosystem entails new risks
Finance
11:59
Turkic states plan to establish common payment systems
Finance
11:56
President Ilham Aliyev: Political ties with Laos have been developing successfully for many years
Foreign policy
11:53
Presidents of Azerbaijan and Laos deliver press statements
Foreign policy
11:51
President Ilham Aliyev: I am confident that bilateral cooperation with Laos will further deepen
Foreign policy
11:50
Azerbaijani fintech companies to test products in Turkic states
Finance
11:43
Azerbaijani parliament ratifies memorandum with UN Climate Secretariat
Milli Majlis
11:42
Azerbaijan's CBA developing data and AI governance framework
Finance
11:40
Azerbaijan and Laos adopt Joint Statement and exchange documents
Foreign policy